News Archive - Page 8 of 118 - Life Sciences Scotland

Clear

NodThera Announces Close of $55 Million Series B Financing

inancing round led by Novo Ventures and includes new investors Cowen Healthcare Investments and Sanofi Ventures, as well as existing...

4th Jun 2020

€5 million boost for coronavirus drug search

The University of Dundee’s Drug Discovery Unit (DDU) has received €5 million of funding to develop antiviral treatments for Covid-19...

2nd Jun 2020

Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19

neumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment...

28th May 2020

National Manufacturing Institute Scotland leadership team bolstered with CEO appointment

The National Manufacturing Institute Scotland has announced that John Reid has been appointed as Chief Executive Officer to lead the...

28th May 2020

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, today announces that its Phase II clinical study has...

26th May 2020

Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO

Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes to remove disease causing proteins...

21st May 2020

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News